Luc-André Granier founded Advicenne SA. Dr. Granier is Chairman, CEO & Medical Director at this company.
He is also on the board of Theranexus SA (former Chairman-Supervisory Board) and Member of International League Against Epilepsy and Member of Société Française d'Etude et de Traitement de la Douleur.
In his past career Dr. Granier held the position of Head-Clinical Research Unit at FORENAP Pharma SARL, Senior Clinical Research Physician at Eli Lilly & Co., Vice President-Clinical Research at Synt:em SA and Member of International Association for the Study of Pain.
Luc-André Granier received a doctorate from the University of Strasbourg.